Europe L-carnosine market is estimated to grow at a CAGR of around 4.3% during the forecast period. The market is driven by increasing diabetes, eye disorders (cataracts), and kidney-related disorders. There is a growing demand for L-carnosine for the prevention and treatment of complications associated with diabetes such as nerve damage, and eye disorders (cataracts). Therefore, the increasing prevalence of diabetes is one of the primary factors which is contributing to the growth of the market. According to IDF Europe, in 2018, more than 58 million diabetic people were living in Europe; this number is expected to reach 66.7 million by 2045. This trend suggests that the demand for L-carnosine in Europe will increase significantly in the near future.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-l-carnosine-market
Europe L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market.
Moreover, the report covers the country-level analysis of the Europe L-carnosine market. The economies covered in the report studied include UK, Germany, Italy, Spain, France, and the Rest of Europe. UK L-carnosine market is estimated to grow significantly during the forecast period. The growth is attributed to the increasing incidence and prevalence rate of chronic diseases, such as CVDs (cardiovascular diseases) and diabetes. The prevalence of diabetes has changed significantly in the UK. It has increased from a year on year growth of 2.9% to 7.6% among men between the period 1994-2016, and 1.9% to 2.6% among women in the same period.
L-carnosine market players are making efforts to develop L-carnosine products for various purposes such as managing aging and cardiovascular health & cellular protection. Bachem AG is a Switzerland-based company offering more than 5,500 different biologically active peptides, amino acid derivatives, and biochemicals through its online portal. It has a global reach with the subsidiaries in the US, UK, and Japan. Moreover, the company has distributors network in Austria, Belgium, Brazil, Canada, France, Germany, India, Italy, Luxembourg, the Netherlands, Spain, and Taiwan. The company offers L-carnosine in a pack size of 5 gm and 25 gm. The list price of 5 gm L-carnosine is $194, and $826 for 25 gm packs.
Europe L-Carnosine Market- Segmentation
By Application
- Autism
- Diabetes
- Skin Support
- Cardiovascular Support
- Joint Support
- Others
A full report of Europe L-Carnosine Market is available at: https://www.omrglobal.com/industry-reports/europe-l-carnosine-market
Europe L-Carnosine Market– Segment by Region
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
